What is Invasive Ductal Carcinoma?
Invasive ductal carcinoma (IDC) is the most common type of breast cancer, accounting for about 70-80% of all breast cancer diagnoses. It begins in the milk ducts and then invades the surrounding breast tissue. If left untreated, IDC can spread to other parts of the body. Early detection and treatment are crucial for a favorable prognosis.
Symptoms
Symptoms of invasive ductal carcinoma may include:
- A lump or thickening in the breast or underarm area.
- Change in size, shape, or appearance of the breast.
- Changes to the skin over the breast, such as dimpling.
- A newly inverted nipple.
- Redness or pitting of the skin over the breast, like the skin of an orange.
- Discharge from the nipple, which may be bloody.
Disease Aetiology (Causes)
The exact cause of IDC, like many cancers, is not fully understood. It is believed to result from a combination of genetic, environmental, and hormonal factors. Risk factors may include age, family history of breast cancer, genetic mutations, reproductive history, and lifestyle factors.
Diagnosis
Diagnosing IDC typically involves:
- Mammography: To detect breast abnormalities.
- Ultrasound or MRI: To further evaluate any suspicious areas seen on a mammogram.
- Biopsy: A sample of breast tissue is taken to determine the type of cells involved and the aggressiveness of the cancer.
- Hormone Receptor and HER2/neu Testing: To assess if the cancer is responsive to hormonal therapies or targeted therapies.
Treatment
Treatment for IDC usually involves a combination of therapies:
- Surgery: Either lumpectomy (removing the tumour and a small margin of surrounding tissue) or mastectomy (removal of the entire breast).
- Radiation Therapy: Often used after lumpectomy to eliminate any remaining cancer cells.
- Chemotherapy: May be recommended before surgery (neoadjuvant therapy) to shrink a tumour, or after surgery (adjuvant therapy) to kill any remaining cancer cells.
- Hormone Therapy: For cancers that are hormone receptor-positive.
- Targeted Therapy: For tumours that are HER2-positive.
What support can we give for the Invasive Ductal Carcinoma?
Invasive Ductal Carcinoma is a rare cancer, meaning it is not as well-known as other forms of cancer. Without a Ribbon is an Australian organisation that provides support for individuals who suffer from rare cancers. So, we provide a designated platform for Warriors to obtain information specific to their Rare Cancer. We also provide annual opportunities for our Warriors to meet and learn from each other. If you suffer from rare cancer such as Invasive Ductal Carcinoma, we can help and support you through your journey thanks to the generous donations we receive. Click the link below to sign up and become a Warrior today!
You can help us with your donation:
Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:
